RxDoctor Payments Data

Salaheddin Elrokhsi

Pediatric Endocrinology · Omaha, NENPI 1174939540

Payments from drug & device makers

$1,516in general payments, 2019–2025

Across 60 payments — averaging $25.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insulet Corporation$244
  • Novo Nordisk$170
  • BETA Bionics, Inc.$166
  • Medtronic$152
  • AbbVie$126
  • Abbott$122
  • plus $535 from 15 others

What the payments were for

  • Food & beverage$1,516100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric endocrinology providers in Nebraskato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium19$102

Paid to pharmacies, not to this prescriber.

Other pediatric endocrinology in Omaha

Where these figures come from

Is this you, or does something look wrong? →